• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受留置导管持续腹腔穿刺术的患者发生腹膜感染的频率。

Frequency of peritoneal infections among patients undergoing continuous paracentesis with an indwelling catheter.

作者信息

Nadir Abdul, Van Thiel David H

机构信息

Maricopa Medical Centre, Phoenix AZ, USA.

出版信息

J Ayub Med Coll Abbottabad. 2010 Jan-Mar;22(1):37-41.

PMID:21409900
Abstract

BACKGROUND

Ascites is a common clinical manifestation of advanced liver disease which can be managed with repeated large volume paracentesis. We sought to determine if continuous paracentesis via placement of an indwelling catheter for the management of ascites is safe and effective.

METHODS

We placed 38 peritoneal drainage catheters in 30 patients for durations ranging from 1-10 days. Patients underwent ascites fluid culture and cell count determinations immediately before and after the completion of paracentesis. Serum WBC count, BUN and creatinine levels were available on all patients before and after paracentesis. The descriptive data were analysed to assess the rate of peritoneal infections, change in renal function and ultimate clinical outcome of patients.

RESULTS

A mean 12.73 litres of peritoneal fluid was removed via continuous peritoneal drainage accomplished with the use of an indwelling abdominal catheter. Eight peritoneal cultures obtained after paracentesis grew out. The mean peritoneal cell count before and after paracentesis in each subject did not show evidence for spontaneous bacterial peritonitis. Five patients underwent successful liver transplantation (OLTX) and did not develop any peritoneal infections post OLTX.

CONCLUSION

Continuous large volume paracentesis using an indwelling abdominal catheter for several days is effective in removing large volumes of peritoneal fluid in patients with endstage-liver-disease (ESLD). The peritoneal fluid can grow out bacteria if it is left in the abdomen for > or = 3 days.

摘要

背景

腹水是晚期肝病的常见临床表现,可通过反复大量腹腔穿刺术进行处理。我们试图确定通过放置留置导管进行持续性腹腔穿刺术治疗腹水是否安全有效。

方法

我们为30例患者放置了38根腹膜引流导管,持续时间为1至10天。患者在腹腔穿刺术完成前后立即进行腹水培养和细胞计数测定。所有患者在腹腔穿刺术前后均有血清白细胞计数、血尿素氮和肌酐水平的数据。对描述性数据进行分析,以评估腹膜感染率、肾功能变化及患者的最终临床结局。

结果

通过使用留置腹腔导管进行持续腹膜引流,平均引出12.73升腹膜液。腹腔穿刺术后获得的8份腹膜培养物有细菌生长。每个受试者腹腔穿刺术前后的平均腹腔细胞计数未显示自发性细菌性腹膜炎的迹象。5例患者成功接受肝移植(原位肝移植),肝移植后未发生任何腹膜感染。

结论

使用留置腹腔导管进行持续大量腹腔穿刺术数天,对于晚期肝病(ESLD)患者有效引出大量腹膜液。如果腹膜液在腹腔内留置≥3天,可能会有细菌生长。

相似文献

1
Frequency of peritoneal infections among patients undergoing continuous paracentesis with an indwelling catheter.接受留置导管持续腹腔穿刺术的患者发生腹膜感染的频率。
J Ayub Med Coll Abbottabad. 2010 Jan-Mar;22(1):37-41.
2
Peritoneal catheter site metastasis in a patient with advanced ovarian cancer.晚期卵巢癌患者的腹膜导管部位转移
Am J Hosp Palliat Care. 2012 May;29(3):241-2. doi: 10.1177/1049909111409390. Epub 2011 May 23.
3
Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis.通过永久性隧道式腹膜导管进行难治性腹水的家庭引流可安全替代大量腹腔穿刺放液术。
Eur J Gastroenterol Hepatol. 2017 May;29(5):539-546. doi: 10.1097/MEG.0000000000000837.
4
Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites.在超声和荧光透视引导下进行隧道式腹膜导管置入术用于恶性腹水的姑息治疗。
AJR Am J Roentgenol. 2001 Sep;177(3):615-8. doi: 10.2214/ajr.177.3.1770615.
5
Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis.在接受治疗性腹腔穿刺术的难治性腹水无症状门诊患者中,未被怀疑的感染并不常见。
Am J Gastroenterol. 1999 Oct;94(10):2972-6. doi: 10.1111/j.1572-0241.1999.01445.x.
6
Drainage pouch: palliating the persistent leak.引流袋:缓解持续性渗漏。
Medsurg Nurs. 2013 Mar-Apr;22(2):125-7.
7
Prognosis of patients with ascites after PleurX insertion: an observational study.PleurX置管术后腹水患者的预后:一项观察性研究。
Scand J Gastroenterol. 2018 Mar;53(3):340-344. doi: 10.1080/00365521.2018.1436190. Epub 2018 Feb 7.
8
Permanent indwelling peritoneal catheters for palliation of refractory ascites in end-stage liver disease: A systematic review.终末期肝病难治性腹水患者行永久性留置腹膜导管姑息治疗的系统评价。
Liver Int. 2019 Sep;39(9):1594-1607. doi: 10.1111/liv.14162. Epub 2019 Jul 17.
9
Percutaneous placement of peritoneal port-catheter in patients with malignant ascites.恶性腹水患者经皮置入腹膜端口导管
Cardiovasc Intervent Radiol. 2007 Mar-Apr;30(2):232-6. doi: 10.1007/s00270-005-0252-4.
10
Peritoneal ports for treatment of intractable ascites.用于治疗顽固性腹水的腹膜端口
J Vasc Interv Radiol. 2005 Mar;16(3):363-8. doi: 10.1097/01.RVI.0000147082.05392.2B.

引用本文的文献

1
Drainage of ascites in cirrhosis.肝硬化腹水的引流
World J Hepatol. 2024 Sep 27;16(9):1245-1257. doi: 10.4254/wjh.v16.i9.1245.
2
Continuous passive paracentesis versus large-volume paracentesis in the prevention and treatment of intra-abdominal hypertension in the critically ill cirrhotic patient with ascites (COPPTRIAHL): study protocol for a randomized controlled trial.连续被动腹腔穿刺术与大量腹腔穿刺术在预防和治疗肝硬化腹水危重症患者腹腔内高压中的应用(COPPTRIAHL):一项随机对照试验的研究方案。
Trials. 2023 Aug 15;24(1):534. doi: 10.1186/s13063-023-07541-4.
3
Clinical implications of prompt ascitic drain removal in cirrhosis with refractory ascites.
肝硬化难治性腹水及时腹腔引流的临床意义。
Singapore Med J. 2021 Dec;62(12):659-664. doi: 10.11622/smedj.2021049. Epub 2021 Apr 19.
4
HEP-Net opinion on the management of ascites and its complications in the setting of decompensated cirrhosis in the resource constrained environment of Pakistan.HEP-Net关于在巴基斯坦资源有限环境下失代偿期肝硬化患者腹水及其并发症管理的意见。
Pak J Med Sci. 2020 Jul-Aug;36(5):1117-1132. doi: 10.12669/pjms.36.5.2407.
5
Large-volume paracentesis with indwelling peritoneal catheter and albumin infusion: a community hospital study.留置腹腔导管并输注白蛋白的大量腹腔穿刺术:一项社区医院研究。
J Community Hosp Intern Med Perspect. 2016 Oct 26;6(5):32421. doi: 10.3402/jchimp.v6.32421. eCollection 2016.
6
The Palliative Management of Refractory Cirrhotic Ascites Using the PleurX (©) Catheter.使用 PleurX(©)导管对难治性肝硬化腹水进行姑息性管理。
Can J Gastroenterol Hepatol. 2016;2016:4680543. doi: 10.1155/2016/4680543. Epub 2016 Jun 5.
7
Continuous peritoneal drainage of large-volume ascites.大量腹水的持续腹腔引流。
Dig Dis Sci. 2011 Sep;56(9):2723-7. doi: 10.1007/s10620-011-1792-x. Epub 2011 Jul 7.